Kraig Biocraft Valuation

KBLB Stock  USD 0.09  0.00  0.00%   
Kraig Biocraft seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Kraig Biocraft Labs from analyzing the firm fundamentals such as Shares Outstanding of 1.02 B, shares owned by institutions of 0.01 %, and Return On Asset of -0.32 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
0.09
Please note that Kraig Biocraft's price fluctuation is out of control at this time. Calculation of the real value of Kraig Biocraft Labs is based on 3 months time horizon. Increasing Kraig Biocraft's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kraig otc stock is determined by what a typical buyer is willing to pay for full or partial control of Kraig Biocraft Labs. Since Kraig Biocraft is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kraig OTC Stock. However, Kraig Biocraft's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.09 Real  0.0756 Hype  0.09 Naive  0.0902
The real value of Kraig OTC Stock, also known as its intrinsic value, is the underlying worth of Kraig Biocraft Labs OTC Stock, which is reflected in its stock price. It is based on Kraig Biocraft's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kraig Biocraft's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.08
Real Value
3.91
Upside
Estimating the potential upside or downside of Kraig Biocraft Labs helps investors to forecast how Kraig otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kraig Biocraft more accurately as focusing exclusively on Kraig Biocraft's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.090.090.09
Details
Hype
Prediction
LowEstimatedHigh
0.000.093.92
Details
Naive
Forecast
LowNext ValueHigh
00.093.92
Details

Kraig Biocraft Total Value Analysis

Kraig Biocraft Labs is now expected to have valuation of 34.14 M with market capitalization of 38.03 M, debt of 95.24 K, and cash on hands of 4.82 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Kraig Biocraft fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
34.14 M
38.03 M
95.24 K
4.82 M

Kraig Biocraft Asset Utilization

One of the ways to look at asset utilization of Kraig is to check how much profit was generated for every dollar of assets it reports. Kraig Biocraft Labs secures a negative usage of assets of -0.32 %, losing $0.00319 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Kraig Biocraft Labs shows how discouraging it operates for each dollar spent on its assets.

Kraig Biocraft Ownership Allocation

Kraig Biocraft Labs maintains a total of 1.02 Billion outstanding shares. Kraig Biocraft Labs holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Kraig Biocraft Profitability Analysis

Net Loss for the year was (8.05 M) with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kraig Biocraft's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kraig Biocraft and how it compares across the competition.

About Kraig Biocraft Valuation

The otc valuation mechanism determines Kraig Biocraft's current worth on a weekly basis. Our valuation model uses a comparative analysis of Kraig Biocraft. We calculate exposure to Kraig Biocraft's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kraig Biocraft's related companies.
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.

8 Steps to conduct Kraig Biocraft's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Kraig Biocraft's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kraig Biocraft's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Kraig Biocraft's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Kraig Biocraft's revenue streams: Identify Kraig Biocraft's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Kraig Biocraft's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Kraig Biocraft's growth potential: Evaluate Kraig Biocraft's management, business model, and growth potential.
  • Determine Kraig Biocraft's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kraig Biocraft's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Kraig Biocraft Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding927.4 M
Retained Earnings-42.8 M
Shares Float767.2 M

Complementary Tools for Kraig OTC Stock analysis

When running Kraig Biocraft's price analysis, check to measure Kraig Biocraft's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kraig Biocraft is operating at the current time. Most of Kraig Biocraft's value examination focuses on studying past and present price action to predict the probability of Kraig Biocraft's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kraig Biocraft's price. Additionally, you may evaluate how the addition of Kraig Biocraft to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk